drugset / Trial / NCT00576576

Evaluation of Atorvastatin on Atherosclerosis Composition

NCT00576576

Completed 27 enrolled Emory University Pfizer · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of Atorvastatin on the coronary atherosclerosis plaque morphology.

Timeline

Start
2007-07
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg

Indications